Phase 2 trial of single agent ifosfamide/mesna in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent.
暂无分享,去创建一个
G. Sutton | M. Markman | J. Hurteau | A. Kennedy | J. Belinson | K. Webster | B. Kulp | G. Peterson